Global Health Insights
Dive into the latest trending topics in global health with IHME’s Global Health Insights blog. Our health researchers explain the significance of new studies, share data related to current events, and help you understand the story behind the numbers.
Community Health Workers are key to remote global care
On behalf of the Community Health Impact Coalition (CHIC), Dr. Madeleine Ballard, global health leader and CEO of CHIC, is the Institute for Health Metrics and Evaluation’s 2024 Roux Prize winner.
Q&A: The rate of common colds and ear infections are declining
Despite declining rates, the number of new episodes has increased due to population growth, with 12.8 billion new episodes of URIs and 390 million new episodes of otitis media in 2021, as estimated by our study.
AMR is a major threat to global health
The latest Global Burden of Disease Study (GBD) study on AMR is the most comprehensive to date. It looks at what’s driving AMR trends, which groups are impacted the most, and what can be done to address this major global health threat.
Q&A: Strokes are becoming more common in people under age 70
Deaths from stroke have increased by 44% since 1990, and they are expected to continue rising. IHME's Dr. Valery Feigin shares the latest findings on stroke, and forecasts through 2050.
Q&A: Antimicrobial resistance is a growing health threat
Our research suggests that deaths from antibiotic resistance will accelerate over the next 30 years, and combatting this threat will require a One Health approach.
Forecasting the state of world health in 2050
Can we see the future in the present? How will the world be impacted by conditions including diabetes and other non-communicable diseases? The latest Global Burden of Disease Study (GBD) forecasts disease burden scenarios for more than 200 countries through 2050.
From air pollution to smoking, which risk factors contribute the most to health loss?
Understanding the relationship between risk factors and health outcomes is key to improving health and developing evidence-based policy.
Disparities in disease burden between males and females
Males and females have unique health concerns that grow over time. Females show higher rates of health loss from conditions including depressive disorders, anxiety, Alzheimer’s and other dementias. Males show higher rates of health loss from cardiovascular, respiratory, and liver diseases.
Q&A: How did the COVID-19 pandemic impact lower respiratory infection burden?
Measures to slow the spread of COVID-19 also worked to prevent other lower respiratory infections, like influenza and RSV. IHME Associate Professor Dr. Hmwe Hmwe Kyu shares new findings from the Global Burden of Disease study.
Why PEPFAR matters, with Dr. Anthony Fauci
PEPFAR has saved more than 25 million lives and provides funding for AIDS treatment and education programs across Africa and into Asia and the Americas. But the President’s Emergency Plan for AIDS Relief faces new uncertainty in terms of long-term financial support.
Q&A: Preparing for a low-fertility future
By 2050, more than three-quarters of countries will not have fertility rates high enough to sustain population size over time. Dr. Austin Schumacher shares the latest Global Burden of Disease findings on past and future trends in global fertility.
Q&A: Ending tuberculosis
Despite concerted efforts, global milestones to end TB by 2020 were not met. Dr. Hmwe Hmwe Kyu shares the latest data on tuberculosis eradication.
Q&A: The global burden of nervous system disorders
In 2021, nervous system disorders like Alzheimer's disease, stroke, and epilepsy affected 40% of the population. Researcher Jaimie Steinmetz shares the latest findings from IHME's GBD study.
Introducing GBD 2021
IHME Director Dr. Christopher Murray discusses what makes the Global Burden of Disease Study (GBD) unique as the most comprehensive effort to measure health trends and why GBD remains more relevant than ever.
Q&A: Introducing GBD 2021
IHME Director Dr. Christopher Murray discusses what makes the Global Burden of Disease Study (GBD) unique as the most comprehensive effort to measure health trends and why GBD remains more relevant than ever.